$2.90-0.10 (-3.17%)
KORU Medical Systems, Inc.
KORU Medical Systems, Inc. in the Healthcare sector is trading at $3.00 with a market capitalization of $144M. Wall Street consensus targets $6.25 (4 analysts), implying a +108.3% move over the next 12 months. The stock is currently near its 52-week low of $2.86, remaining 28.4% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 30 is oversold, raising the odds of a near-term bounce. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Total Revenue | $10.19Mβ | $10.40Mβ | $10.90Mβ | $11.76Mβ | $12.05M |
| Gross Profit | $6.48Mβ | $6.26Mβ | $6.82Mβ | $7.23Mβ | $7.85M |
| Operating Income | -$312,655β | -$867,679β | -$547,104β | -$864,923β | $626,991 |
| Net Income | -$206,867β | -$777,966β | -$486,856β | -$807,078β | $252,449 |
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to del...